Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
46.99 USD | +0.36% | +0.53% | -1.93% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.93% | 3.85B | |
+2.75% | 108B | |
+9.85% | 104B | |
+6.58% | 23.66B | |
-12.47% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.16% | 16.19B | |
+4.42% | 13.72B | |
+34.78% | 12.22B |
- Stock
- Equities
- Stock Ultragenyx Pharmaceutical Inc. - Nasdaq
- News Ultragenyx Pharmaceutical Inc.
- Ultragenyx Pharmaceutical : Obtains Canadian Approval of Dojolvi for Treatment of Fatty Acid Oxidation Disorders